Mucormycosis — A New Risk of Deferoxamine Therapy in Dialysis Patients with Aluminum or Iron Overload?
Authors:
- J J GoodillJGJ J Goodill
- J G AbueloJAJ G Abuelo
- 2 July 1987
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 317 (1) , 54
Abstract
Correspondence from The New England Journal of Medicine — Mucormycosis — A New Risk of Deferoxamine Therapy in Dialysis Patients with Aluminum or Iron Overload?Keywords
This publication has 7 references indexed in Scilit:
- Myocardial Mucormycosis With Emboli in a Hemodialysis PatientAmerican Journal of Kidney Diseases, 1986
- REPLYAustralian and New Zealand Journal of Medicine, 1985
- EFFECT OF AN IRON‐CHELATING AGENT ON LYMPHOCYTE PROLIFERATIONImmunology & Cell Biology, 1984
- Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferationBlood, 1984
- DESFERRIOXAMINE AND SYSTEMIC YERSINIOSISThe Lancet, 1983
- Host Defenses and Infectious Complications in Maintenance Hemodialysis Patients1983
- Mucormycotic slough of nasal floor and palate in the anephric patientThe Journal of the American Dental Association, 1979